Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

3.88
Delayed Data
As of 4:00pm ET
 -0.07 / -1.77%
Today’s Change
1.97
Today|||52-Week Range
5.78
+79.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues22.4M26.8M44.7M57.6M
 
 
 
 
 
Cost of Goods Sold12.1M14.6M21.4M35.8M
 
 
 
 
 
Depreciation And Amortization986.0K1.0M1.5M2.5M
 
 
 
 
 
 
Operating ExpensesGross Income9.3M11.2M21.7M19.4M
 
 
 
 
 
General Expenses45.0M61.7M78.1M47.6M
 
 
 
 
 
Research And Development27.7M43.0M59.5M28.3M
 
 
 
 
 
Total Operating Expenses58.1M77.3M101.0M85.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-35.7M-50.5M-56.4M-28.3M
 
 
 
 
 
Extraordinary Credit0.000.00600.0K0.00
 
 
Interest Expense On Debt5.0K0.000.007.0K
 
 
 
Other Expenses0.00-1.0K-14.0K0.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-35.4M-50.4M-55.7M-28.2M
 
 
 
 
 
Preferred Dividend-401.0K-3.7M-4.5M-4.6M
 
 
 
 
 
Net Income-35.4M-50.4M-55.7M-28.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.1M26.1M30.9M37.1M
 
 
 
 
 
Shares To Calculate EPS Diluted23.1M26.1M30.9M37.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.54-$2.10-$1.96-$6.16
 
 
 
 
 
EPS Diluted-$1.54-$2.10-$1.96-$0.88